<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03489538</url>
  </required_header>
  <id_info>
    <org_study_id>EK1143</org_study_id>
    <nct_id>NCT03489538</nct_id>
  </id_info>
  <brief_title>Homocysteine After Laparoscopic Roux-enY Gastric Bypass</brief_title>
  <official_title>Homocysteine After Laparoscopic Roux-enY Gastric Bypass: a Comprehensive Evalutation in 708 Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Changes in homocysteine values after bariatric surgery remain controversially discussed. This
      is the first comprehensive summary to depict timeline changes in homocysteine levels
      following laparoscopic roux-en-Y gastric bypass.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Homocysteine is an independent risk factor for cardiovascular disease. Changes in
      homocysteine levels following bariatric surgery remain controversially discussed.

      708 consecutive patients underwent laparoscopic roux-en-Y gastric bypass over a 6 year
      period. Throughout their routine follow-up, demographic data as well as homocysteine, folate
      and vitamin B12 were retrospectively collected at the timepoints: preoperatively, at 3, 6, 9,
      12, 18, 24, 36, 48, 60, 72, 84, and 96 months postoperatively.

      In order to reveal clinical relevance of the results, patients were sent a special
      questionnaire accompanied by an informed consent form for participation and asked for
      cardiovascular disease events (myocardial infarction, stroke, deep venous thrombosis) or any
      other hospital stay after the surgery and cross checked with two region wide databases which
      account for approx. 80% of all hospital contacts in the region. Additionally, the database
      was networked with the statewide death registry in order to reveal deceased subjects and data
      about their demise through the beforementioned databases was collected.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 9, 2013</start_date>
  <completion_date type="Actual">September 11, 2017</completion_date>
  <primary_completion_date type="Actual">September 11, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Homocysteine in µmol/l assessed by CMIA technique.</measure>
    <time_frame>timepoints: preoperatively, 3, 6, 9, 12, 18, 24, 36, 48, 60, 72, and 96 months postoperatively</time_frame>
    <description>Measured by Chemiluminescent microparticle immunoassay (CMIA) technique in µmol/l.
Change of homocysteine over the timeframe at the timepoints: preoperatively, 3, 6, 9, 12, 18, 24, 36, 48, 60, 72, and 96 months postoperatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Weight in kg measured by a standard scale.</measure>
    <time_frame>timepoints: preoperatively, 3, 6, 9, 12, 18, 24, 36, 48, 60, 72, and 96 months postoperatively</time_frame>
    <description>Change of weight in kg over the timeframe at the timepoints: preoperatively, 3, 6, 9, 12, 18, 24, 36, 48, 60, 72, and 96 months postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Folate in nmol/l assessed by ELCIA method.</measure>
    <time_frame>timepoints: preoperatively, 3, 6, 9, 12, 18, 24, 36, 48, 60, 72, and 96 months postoperatively</time_frame>
    <description>ELCIA: electrochemiluminescent immunoassay Change of folate in nmol/l over the timeframe at the timepoints preoperatively, 3, 6, 9, 12, 18, 24, 36, 48, 60, 72, and 96 months postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vitamin B12 in pmol/l assessed by CMIA technique.</measure>
    <time_frame>timepoints: preoperatively, 3, 6, 9, 12, 18, 24, 36, 48, 60, 72, and 96 months postoperatively</time_frame>
    <description>Change of vitamin B12 in pmol/l over the timeframe at the timepoints preoperatively, 3, 6, 9, 12, 18, 24, 36, 48, 60, 72, and 96 months postoperatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of cardiovascular events assessed by a questionnaire and cross checking with 2 state wide databases.</measure>
    <time_frame>Through study attendance the specific date of the incident was assessed and assigned to the timepoints: preoperatively, 3, 6, 9, 12, 18, 24, 36, 48, 60, 72, and 96 months postoperatively</time_frame>
    <description>Assessed conditions: events of myocardial infarction, stroke, deep vein thrombosis and peripheral artery disease which were not preexistent.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">708</enrollment>
  <condition>Obesity, Morbid</condition>
  <condition>Homocystine; Metabolic Disorder</condition>
  <condition>Bariatric Surgery Candidate</condition>
  <condition>Folate Deficiency</condition>
  <condition>Vitamin B 12 Deficiency</condition>
  <arm_group>
    <arm_group_label>RYGB Patients</arm_group_label>
    <description>Laparoscopic long limb roux-en-Y gastric bypass group. All consecutive patients eligible for bariatric surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic long limb roux-en-Y gastric bypass</intervention_name>
    <description>standard laparoscopic roux-en-Y gastric bypass (biliopancreatic limb 40 to 60 cm, alimentary limb 150 cm)</description>
    <arm_group_label>RYGB Patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Collection of blood samples during routine pre- and postoperative visits.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All consecutive patients eligible for bariatric surgery according to the american society
        of metabolic and bariatric surgery criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI &gt; 40kg/m2 or BMI &gt; 35 kg/m2 including relevant comorbidities

          -  Age between 18 to 75 years

          -  suitable for operation, consent

          -  no contraindications for the operation

        Exclusion Criteria:

          -  BMI &lt; 35 kg/m2

          -  age below 18 or above 75 years

          -  not able to consent to the operation

          -  severe medical conditions not applicable for general anaesthesia

          -  non compliance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerhard Prager, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Vienna, Department of Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <results_reference>
    <citation>Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991 Apr 25;324(17):1149-55.</citation>
    <PMID>2011158</PMID>
  </results_reference>
  <results_reference>
    <citation>Williams DB, Hagedorn JC, Lawson EH, Galanko JA, Safadi BY, Curet MJ, Morton JM. Gastric bypass reduces biochemical cardiac risk factors. Surg Obes Relat Dis. 2007 Jan-Feb;3(1):8-13. Epub 2006 Dec 27.</citation>
    <PMID>17196442</PMID>
  </results_reference>
  <results_reference>
    <citation>Woodard GA, Peraza J, Bravo S, Toplosky L, Hernandez-Boussard T, Morton JM. One year improvements in cardiovascular risk factors: a comparative trial of laparoscopic Roux-en-Y gastric bypass vs. adjustable gastric banding. Obes Surg. 2010 May;20(5):578-82. doi: 10.1007/s11695-010-0088-0. Epub 2010 Feb 26.</citation>
    <PMID>20186576</PMID>
  </results_reference>
  <results_reference>
    <citation>Borson-Chazot F, Harthe C, Teboul F, Labrousse F, Gaume C, Guadagnino L, Claustrat B, Berthezene F, Moulin P. Occurrence of hyperhomocysteinemia 1 year after gastroplasty for severe obesity. J Clin Endocrinol Metab. 1999 Feb;84(2):541-5.</citation>
    <PMID>10022413</PMID>
  </results_reference>
  <results_reference>
    <citation>Dixon JB, Dixon ME, O'Brien PE. Elevated homocysteine levels with weight loss after Lap-Band surgery: higher folate and vitamin B12 levels required to maintain homocysteine level. Int J Obes Relat Metab Disord. 2001 Feb;25(2):219-27.</citation>
    <PMID>11410823</PMID>
  </results_reference>
  <results_reference>
    <citation>Lapointe M, Poirier P, Martin J, Bastien M, Auclair A, Cianflone K. Omentin changes following bariatric surgery and predictive links with biomarkers for risk of cardiovascular disease. Cardiovasc Diabetol. 2014 Aug 21;13:124. doi: 10.1186/s12933-014-0124-9.</citation>
    <PMID>25139582</PMID>
  </results_reference>
  <results_reference>
    <citation>Sheu WH, Wu HS, Wang CW, Wan CJ, Lee WJ. Elevated plasma homocysteine concentrations six months after gastroplasty in morbidly obese subjects. Intern Med. 2001 Jul;40(7):584-8.</citation>
    <PMID>11506296</PMID>
  </results_reference>
  <results_reference>
    <citation>Toh SY, Zarshenas N, Jorgensen J. Prevalence of nutrient deficiencies in bariatric patients. Nutrition. 2009 Nov-Dec;25(11-12):1150-6. doi: 10.1016/j.nut.2009.03.012. Epub 2009 May 31.</citation>
    <PMID>19487104</PMID>
  </results_reference>
  <results_reference>
    <citation>Gómez-Ambrosi J, Pastor C, Salvador J, Silva C, Rotellar F, Gil MJ, Catalán V, Rodríguez A, Cienfuegos JA, Frühbeck G. Influence of waist circumference on the metabolic risk associated with impaired fasting glucose: effect of weight loss after gastric bypass. Obes Surg. 2007 May;17(5):585-91. Erratum in: Obes Surg. 2007 Jul;17(7):996.</citation>
    <PMID>17658015</PMID>
  </results_reference>
  <results_reference>
    <citation>Ledoux S, Coupaye M, Bogard C, Clerici C, Msika S. Determinants of hyperhomocysteinemia after gastric bypass surgery in obese subjects. Obes Surg. 2011 Jan;21(1):78-86. doi: 10.1007/s11695-010-0269-x.</citation>
    <PMID>20814760</PMID>
  </results_reference>
  <results_reference>
    <citation>Sledzinski T, Goyke E, Smolenski RT, Sledzinski Z, Swierczynski J. Decrease in serum protein carbonyl groups concentration and maintained hyperhomocysteinemia in patients undergoing bariatric surgery. Obes Surg. 2009 Mar;19(3):321-6. doi: 10.1007/s11695-008-9691-8. Epub 2008 Oct 2.</citation>
    <PMID>18830787</PMID>
  </results_reference>
  <results_reference>
    <citation>Tedesco AK, Biazotto R, Gebara TS, Cambi MP, Baretta GA. PRE- AND POSTOPERATIVE IN BARIATRIC SURGERY: SOME BIOCHEMICAL CHANGES. Arq Bras Cir Dig. 2016;29Suppl 1(Suppl 1):67-71. doi: 10.1590/0102-6720201600S10017. English, Portuguese.</citation>
    <PMID>27683780</PMID>
  </results_reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 22, 2018</study_first_submitted>
  <study_first_submitted_qc>March 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2018</study_first_posted>
  <last_update_submitted>March 29, 2018</last_update_submitted>
  <last_update_submitted_qc>March 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Gerhard Prager</investigator_full_name>
    <investigator_title>associate professor, MD</investigator_title>
  </responsible_party>
  <keyword>bariatric surgery</keyword>
  <keyword>gastric bypass</keyword>
  <keyword>homocysteine</keyword>
  <keyword>folate</keyword>
  <keyword>vitamin b12</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Obesity, Morbid</mesh_term>
    <mesh_term>Vitamin B 12 Deficiency</mesh_term>
    <mesh_term>Folic Acid Deficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to share individual participant data to other researchers yet.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

